NCT00620659: Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015) |
|
|
| Terminated | 2a | 125 | US | Comparator: MK0249, Comparator: placebo, Comparator: modafinil | Merck Sharp & Dohme LLC | Sleep Apnea, Obstructive, Hypopnea Syndrome, Excessive Daytime Sleepiness | 02/09 | 02/09 | | |
